Doctor in Molecular Genetics. After ten years of academic research in Spain and the United States, in 1997 he entered the pharmaceutical industry in project management and business development roles. In 2001 he left the pharmaceutical company to dedicate himself to the development of projects and creation of biomedical companies arising from the scientific activity of universities.
and research centers, an activity that he has not abandoned since then. He also collaborates in undergraduate and postgraduate training activities related to the business of biomedicine and knowledge transfer.